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Objective: Since bisphenol A (BPA) has been shown to induce obesity in experimental studies, we
explored the associations between BPA and fat mass, fat distribution and circulating levels of adiponectin,
leptin and ghrelin in humans.
Methods: In the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS), fat mass and fat
distribution were determined in 70-year-old men and women (n = 890) by dual-energy X-ray absorpti-
ometry (DXA) and magnetic resonance imaging (MRI) (n = 287). Serum levels of BPA were analyzed using
isotope liquid chromatography/tandem mass spectrometer (API4000LC–MS/MS). Hormone levels were
analyzed with radioimmunoassays (RIA) or enzyme-linked immunosorbent assay (ELISA). Imaging was
performed approximately two years following collection of other data.
Results: Serum concentrations of BPA were not related to adipose tissue measurements by DXA or MRI.
BPA associated positively with adiponectin and leptin, but negatively with ghrelin, following adjustments
for sex, height, fat mass, lean mass, smoking, alcohol consumption, physical activity, energy intake, and
educational levels (p < 0.001, p = 0.009, p < 0.001, respectively). The relationship between BPA and ghrelin
was stronger in women than in men.
Conclusion: Although no relationships between BPA levels and measures of fat mass were seen, BPA asso-
ciated strongly with the adipokines adiponectin and leptin and with the gut-hormone ghrelin suggesting
that BPA may interfere with hormonal control of hunger and satiety.
 2014 Published by Elsevier Ltd.1. Introduction
Obesity is a major health concern in the Western world and is
also increasing in developing countries. Obesity is most often
blamed to be due to excess caloric intake in relation to a reducedphysical activity (Sallis and Glanz, 2009; Westerterp, 2010; Mitch-
ell et al., 2011). Although an imbalance between energy intake and
output clearly is a determinant of body weight, other factors might
also be of importance. During the last decade the hypothesis that
some anthropogenic chemicals act as obesogens promoting fat
accumulation has been put forward (Baillie-Hamilton, 2002;
Grün and Blumberg, 2009). This hypothesis deserves further atten-
tion since obesity is considered a global issue of epidemic propor-
tions. Regulation of hunger and satiety is complex and inﬂuenced
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there are especial concerns regarding chemicals that may act as
endocrine disrupters.
The estrogenic properties of bisphenol A (BPA) has been known
since 1936 (Dodds, 1936), but recognized as an environmental
endocrine disrupting compound (EDC), a xenoestrogen, in the late
1990s. Endocrine effects of BPA has been observed in both epide-
miological and experimental studies (Alonso-Magdalena et al.,
2012; Teppala et al., 2012; vom Saal et al., 2012), but yet without
any solid proof of deleterious effects, and therefore more studies
are required. BPA can act by the classical nuclear estrogen receptor
a (ERa) and estrogen receptor b (ERb), but the estrogenicity has
been regarded as weak in relation to endogenous estrogen, and
thus negligible. However, other mechanisms of the estrogen than
the classic nuclear estrogen receptor a (ERa) and estrogen receptor
b (ERb) suggest that there are routes where BPA can act as a rather
potent estrogen, e.g. via membrane-bound estrogen receptors,
mERa, mERb and G protein-coupled receptor 30 (GPR30) (Watson
et al., 2007).
BPA is a high-volume chemical in the plastics industry. It is also
found in cash receipts, can resins and sealants, etc. Most people
worldwide have detectable levels of BPA in their blood or urine
indicating a ubiquitous exposure (Vandenberg et al., 2007; Olsen
et al., 2012). Furthermore, BPA has been shown to induce obesity
in rodents in experimental settings by different groups (Miyawaki
et al., 2007; Somm et al., 2009), and in humans. Lang et al. and
Shankar et al. found urinary BPA to be related to obesity measured
by BMI in the NHANES study performed in adults (Lang et al., 2008;
Shankar et al., 2012). Similar ﬁndings were reported in a Chinese
population (Wang et al., 2012b). In both American and Chinese
school-children, urinary BPA levels were associated with BMI (Tra-
sande et al., 2012; Wang et al., 2012a; Bhandari et al., 2013; Harley
et al., 2013; Li et al., 2013). Valvi and co-workers reported that uri-
nary BPA in pregnant women were related to BMI in their off-
spring at 4 years of age (Valvi et al., 2013). Similar results were
found in another mother/child cohort at age 9 years, but in this
case the association was only found in girls (Harley et al., 2013).
The Prospective Investigation of the Vasculature in Uppsala Se-
niors (PIVUS) study (Lind et al., 2005) is unique in its kind since not
only BMI is determined, but both fat mass and fat distribution have
been measured using both dual-energy X-ray absorptiometry
(DXA) and magnetic resonance imaging (MRI). In addition, some
of the major hormones related to hunger and satiety, such as ghre-
lin, leptin and adoponectin have been measured together with ma-
jor potential confounding variables, such as energy intake, alcohol
intake, exercise habits and education level. We therefore used the
PIVUS study to evaluate the relationships between circulating BPA
levels and different indices of obesity, as well as hormones related
to hunger and satiety.2. Materials and methods
2.1. Study population
Eligible for the study were all men and women aged 70 living in
the community of Uppsala, Sweden from the year 2001 to 2004.
Using the Swedish population register, 2025 individuals were ran-
domly chosen and invited in the way that they would perform the
examination 1–2 months following their 70th birthday. The total
background population turning 70 years in the years between
2001 and 2004 were approximately 7000 individuals. A total of
1016 participated, yielding a participation rate of 50.1% (51.5% wo-
men). They were all examined in the morning after an overnight
fast, and no medication or smoking was allowed after midnight.
Venous blood samples were stored at 70 C until analysis. Fatmass and fat distribution were determined by dual-energy X-ray
absorptiometry (DXA) in 890 individuals, and by magnetic reso-
nance imaging (MRI) in 287 individuals.
The study was approved by the Ethics Committee of the Univer-
sity of Uppsala, and all the participants gave their informed con-
sent before the study. As the participation rate in this cohort was
only 50%, we carried out an evaluation of cardiovascular disorders
and medications in 100 consecutive non-participants. The preva-
lence of cardiovascular drug intake, history of myocardial infarc-
tion, coronary revascularization, antihypertensive medication,
statin use and insulin treatment were similar to those in the inves-
tigated sample, while the prevalence of diabetes, congestive heart
failure and stroke tended to be higher among the non-participants
The study design and the status in non-participants have been de-
scribed in detail in Lind et al. (2005).
2.2. Baseline examination including questionnaire
The participants were asked to answer a questionnaire about
their medical history, educational level, exercise, and smoking hab-
its. Educational level was categorized into three groups: <9 years,
9–12 years and >12 years of education. The individuals were asked
two questions: ‘‘How many times a week do you engage in light
exercise for at least 30 min (activities like walking, cycling, golf,
etc. usually not causing sweating)?’’ and ‘‘How many times a week
do you engage in heavy exercise for at least 30 min (activities like
running, swinging, football, etc. generally causing sweating)?’’
Based on these questions exercise habits were categorized into
four groups: <2 times light exercise (no sweat) per week,P2 times
light exercise per week, 1–2 times heavy exercise (sweat) per
week, >2 times heavy exercise (sweat) per week (Table 2). The die-
tary intakes were assessed by a 7-d food diary in which the partic-
ipants were asked to indicate the intake meal by meal in a list of
different predeﬁned food and drink items, and also to write down
eating between meals. These data were then coded into food items
and processed by a custom-made software program (MatsR,
Västerås, Sweden) to obtain daily caloric and alcohol intake.
2.3. BPA analysis
The serum levels of BPA taken at baseline examination were
analyzed at ALS Environmental Canada. Serum samples (0.5 ml)
were analyzed for levels of BPA (sum of both free and the conju-
gated forms) using isotope liquid chromatography/tandem mass
spectrometer (API 4000LC–MS/MS), as previously described in de-
tail (Olsen et al., 2012). Quality control of the analysis was main-
tained by analyzing a method blank (calf serum) and two spiked
calf serum samples (20 ng mL1, all analytes) along with every
17 samples. The detection limit (LOD) was 0.2 ng mL1 based upon
a lower calibration standard (0.5 ng mL1) which gave an instru-
ment signal to noise response of 3:1. BPA in serum was detectable
in 98 percent of both females and males. As previously published,
the median serum concentration of BPA was 2.1 ng mL1 (range of
<LOD to 24 ng mL1) in females, and 3.9 ng mL1 (range of <LOD to
27.3 ng mL1) in males.
2.4. Adipose tissue quantiﬁcation by DXA and MRI
On average two years following the baseline investigation all
participants in the sample were offered an examination with
dual-energy X-ray absorptiometry (DXA), by which fat mass and
lean mass in different body compartments were estimated (DPX,
Lunar Prodigy, Lunar Corp., Madison, WI, USA). 890 (87%) individ-
uals participated. The analyses included measures of trunk fat
mass, deﬁned as fat between the groins and the shoulders, and
leg fat mass, deﬁned as fat between the groins and the toes, and ra-
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software provided by the manufacturer of the hardware. The ra-
tional for subdivisions of these fat depots is that centrally depos-
ited fat has been shown to relate more closely to cardiovascular
disease than peripherally located fat.
By triple measurements in 15 subjects, the precision error of the
DXAmeasurements was calculated to be 1.5% for total fat mass and
1.0% for total lean mass (Ingelsson et al., 2009). The bias associated
with DXA fat measurement is systematic, with an underestimation
of fat content for lean individuals and an overestimation of fat con-
tent among obese individuals, but these inaccuracies account for
less than 2% of the variation (Wang et al., 2010).
In parallel with the DXA examination, MRI of the abdominal re-
gion was performed in 287 individuals invited in a randommanner
from the PIVUS cohort. For economic reasons the MRI investigation
could not be offered to everybody. The majority of those investi-
gated by MRI did also perform the DXA scanning (n = 276). Visceral
adipose tissue (VAT) and subcutaneous adipose tissue (SAT) areas
(cm2) were manually segmented from a single 10 mm thick axial
steady-state-free precession slice as previously described (Kullberg
et al., 2007). Based on repeated measurements of VAT and SAT in
22 subjects, the reproducibility/coefﬁcients of variation were
found to be 5.9% and 3.4%, respectively. Imaging was performed
on a 1.5 T MRI system (Gyroscan Intera, Philips Medical Systems,
Best, the Netherlands), using the standard quadrature body coil.
The rational for subdivisions of these fat depots is that visceral
fat has been shown to relate more closely to cardio-metabolic dis-
ease, such as diabetes, disease than subcutaneously located fat. The
DXA measurements of trunk fat cannot differentiate between VAT
and SAT.
2.5. Adiponectin, leptin and ghrelin analyses
Adiponectin and leptin in plasma were analyzed at baseline
with double-antibody radioimmunoassays (RIA) (Linco Research,
St. Louis, MO, USA). Total coefﬁcient of variation (CV) for leptin
was 4.7% at both low (2–4 ng mL1) and high (10–15 ng mL1) lev-
els, and for adiponectin the total CV was 15.2% at low (2–
4 lg mL1) and 8.8% at high (26–54 lg mL1) levels.
Serum ghrelin was analyzed at baseline with an enzyme-linked
immunosorbent assay (ELISA) (Ghrelin EIA kit Ek-031-30, Phoenix
Pharmaceuticals, Burlingame, CA, USA). The total CV for the assay
was 5%.
2.6. Statistical analyses
All variables were evaluated regarding non-normality and vari-
ables with a skewed distribution, such as BPA and the hormone
levels, were ln-transformed. Since men and women normally have
different distributions for leptin and adiponectin, with higher lev-
els in women, the levels for those adipocytokines were trans-
formed to the SD scale in men and women separately. This scale
is also called Z-score, and expresses the distance from the mean va-
lue in terms of one standard deviation.
In linear regression models, BPA was related to indices of fat
mass as well as to the three hormones evaluated.
To screen for non-linear relationships, the quadratic term of
BPA was added to the regression models.
Three models were tested. The primary model was adjusted for
sex only. In the second model, adjustments were performed for
sex, height, and lean mass by DXA. In the third model, additional
adjustment was performed for smoking, exercise habits, educa-
tional level, total daily energy intake, and alcohol consumption.
Smoking, educational level, energy intake and alcohol consump-
tion have all previously been linked to exposure to environmental
contaminants and exercise habits are closely linked to obesity.Since data on dietary intake was missing in 155 individuals, miss-
ing data on total daily energy intake, and alcohol consumption
were imputed by using a multiple imputations command (mi) gen-
erating 20 new observations for each missing value. Imputation
was performed in order not to lose 155 individuals in the third
model.
For all outcomes, interactions between the BPA level and sex
were evaluated in the ﬁrst model. If there was an improved ﬁt of
the model with an interaction term included (p < 0.05), separate
sex speciﬁc analyses were performed.
In the present study BPA levels were related to 10 different adi-
pose-tissue-related outcomes. Applying a strict Bonferroni adjust-
ment will result in a critical p-value of 0.005.
STATA 12 (College Station, TX, USA) was used for calculations.3. Results
Basic characteristics for height, weight, fat mass, and fat distri-
bution are given in Table 1. Distributions of educational level,
physical activity, smoking habits, energy intake, and alcohol con-
sumption are presented in Table 2.
3.1. BPA vs. fat mass and fat distribution
No signiﬁcant relationships between BPA levels and indices of
fat mass or fat distribution were found at any level of adjustment
(Table 3).
The interaction between BPA concentration and sex was not sig-
niﬁcant for any of the fat measures studied. Neither did we found
any signiﬁcant relationship between BPA and any of the indices of
obesity evaluated when we stratiﬁed the analysis according to sex.
3.2. BPA vs. adiponectin and leptin levels
After adjustment for sex, serum concentrations of BPA were
positively associated with adiponectin (p < 0.001) and leptin
(p = 0.018) levels.
These results remained signiﬁcant (p < 0.001 and p = 0.009,
respectively) also in the fully adjusted models. The results for
adiponectin and leptin levels were also independent of adjustment
for fat mass (p = 0.0001 for both). Introducing a quadratic term
suggested a non-linear relationship for BPA vs. adiponectin
(p < 0.001), but not vs. leptin. The effect of BPA regarding adiponec-
tin was seen even at rather low levels of circulating BPA.
No signiﬁcant interactions were seen between BPA and sex
regarding the relationships vs. adiponectin or leptin. Neither did
a sex-stratiﬁed analysis reveal any major differences between
men and women regarding the strength or the shape of the rela-
tionships (p < 0.0001 for both men and women regarding adipo-
nectin with almost identical beta-coefﬁcients. For leptin the beta-
coefﬁcient was similar in men and women, 0.076 and 0.087,
respectively, but due to the lower power in the sex-stratiﬁed anal-
ysis the p-values did not reach signiﬁcance, p = 0.13 and p = 0.06
respectively).
3.3. BPA vs. ghrelin level
Serum concentrations of BPA adjusted for sex were negatively
related to serum concentrations of ghrelin also in the fully adjusted
models (p < 0.001). Introducing a quadratic term for BPA in the
models did not reveal any signiﬁcant non-linear effects. The results
were independent of adjustment for fat mass.
The interaction term between BPA and sex was signiﬁcant for
ghrelin (p = 0.04), revealing a stronger relationship between BPA
and ghrelin levels for women, with a regression coefﬁcient about
Table 1
Basic characteristics in males and females. Mean and standard deviation (SD) are given together with minimum (Min) and maximum (Max) values. Median is given together with
the inter quartile rate (IQR) for bisphenol A and the hormones.
Variables Males Females
Mean SD Min–Max N Mean SD Min–Max N
Total fat mass (kg) 23.5 8.2 3.2–51.8 431 27.7 9.2 3.4–55.8 459
Fat leg (kg) 6.3 2.6 1.6–25.1 431 9.7 3.4 1.3–22.9 459
Fat trunk (kg) 14.2 5.1 1.1–30.1 431 13.9 5.0 1.6–28.4 459
VATa (cm3) 119 63 11.3–368 148 94 49 7.1–268 139
SATb (cm3) 189 80.3 46–463 148 262 109 52–727 139
Height (cm) 176 6.4 155–198 431 162 5.7 148–184 459
Weight (kg) 83.8 12.6 53–132 431 70.7 12.4 42–115 459
BMIc (kg m2) 27.1 3.6 17.7–43.4 431 26.9 4.6 16.6–49.8 459
Energy (kcal d1) 2056 531 913–4116 431 1724 416 711–3363 430
Alcohol (g d1) 8.9 9.1 0–61 431 4.4 5.0 0–32 430
Median IQR N Median IQR N
Bisphenol A (ng mL1) 3.9 2.08–6.57 502d 2.1 1.97–6.51 501e
Adiponectin (lg mL1) 4.8 3.0–7.2 429 8.2 5.0–12.0 454
Leptin (ng mL1) 6.4 4.1–9.8 429 17.0 11.0–25.1 454
Ghrelin (ng mL1) 5.6 4.3–7.2 407 6.1 4.5–7.7 432
a Visceral adipose tissue.
b Subcutaneous adipose tissue.
c Body mass index.
d 6 < Level of detection.
e 6 < Level of detection.
Table 2
Distribution of educational levels, physical activity and smoking habits given as
percentage of participants.
Males (n = 427) Females (n = 453)
Sex 48.5 51.5
Education: 1–9 years 54.8 57.6
Education: 9–12 years 18.5 18.3
Education: university level 26.7 24.1
Physical activity: very lighta 13 10
Physical activity: lightb 56 60
Physical activity: mediumc 22 25
Physical activity: hardd 9 5
Current smokers 9.5 10.7
a Light exercise, no sweat <2 times week1.
b Light exercise, no sweat P2 times week1.
c Hard exercise, sweat 1–2 times week1.
d Hard exercise, sweat >2 times week1.
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relationships between BPA and ghrelin levels were very similar in
individuals with a fat mass above the median compared to those
below the median (linear regression coefﬁcient 0.09, p < 0.001
for both strata).4. Discussion
4.1. BPA and obesity
Numerous studies, both experimental and epidemiological,
have shown an association between BPA and obesity and other
metabolic effects, such as insulin resistance and dyslipidemia
(Miyawaki et al., 2007; Wei et al., 2011; Trasande et al., 2012;
vom Saal et al., 2012; Wang et al., 2012b; Bhandari et al., 2013)
In the present study, we could not detect any relationship between
BPA and obesity indices despite the fact that we used both DXA and
MRI to characterize fat mass. However, obesity is a multifactorial
disease (Speakman and O’Rahilly, 2012) and weight gain often oc-
cur at a rather slow pace. These features regarding etiology and
time-course of obesity development will make it difﬁcult to estab-
lish a relationship between BPA in serum measured at one timepoint and fat volume in this elderly cohort, mainly exposed as
adults. Hormone levels on the other hand generally respond rela-
tively fast to changes in the environment and therefore a relation-
ship between hormone levels and BPA in the circulation measured
at the same time point is more likely to be revealed than a poten-
tial relationship between BPA levels and fat mass.4.2. BPA as an endocrine disruptor
BPA was developed as a synthetic estrogen, a xenoestrogen
(Dodds, 1936). BPA initiates rapid responses through membrane-
bound estrogen receptors with about the same potency as 17b-
estradiol (E2) (Welshons et al., 2006; Alonso-Magdalena et al.,
2012), but the afﬁnity to the classical nuclear ERa and ERb recep-
tors is much lower than that of the endogenous hormone.
In women decreased levels of estrogen after menopause in-
crease the incidence of obesity and risk for the metabolic syndrome
(Carr, 2003). In female rats ovariectomy (OVX) leads to increased
food intake and weight gain. These effects are counteracted by
E2 supplementation in therapeutic doses (20 lg kg1 d1) (Kafkas
et al., 2012), demonstrating the importance of estrogen in the con-
trol of energy balance and fat accumulation.
Interactions between estrogens and adipokines and ghrelin
have been described. Estradiol reduces the orexigenic potency of
ghrelin as demonstrated in male rats and OVX female rats given
exogenous ghrelin, resulting in increased food intake, which is re-
versed by E2 treatment. (Clegg et al., 2007). Leptin sensitivity in
the brain is inﬂuenced by estrogen, and estradiol restores the cen-
tral leptin sensitivity in OVX female rats. Such treatment also re-
sults in increases in subcutaneous fat deposition (Clegg et al.,
2006).
The thyroid system is another hormonal pathway inﬂuencing
metabolism that might be affected by BPA. An inverse association
between urinary BPA and TSH and positive association with free
T3, i.e. an increase in thyroid function, were shown in a cross-sec-
tional study by Wang et al. (2013), but other studies have shown
the opposite effect (Sriphrapradang et al., 2013). If BPA increases
thyroid function this could possibly mask an obesogenic effect of
BPA through an increased metabolic rate.
Table 3
Relationships between bisphenol A (BPA) concentration in serum and fat mass and hormone levels related to fat mass, hunger and satiety. Relationships are given for BPA as a
continuous variable (regression coefﬁcient using ln-transformed values).
Variable N Model 1: gender adjusted Model 2: body stature adjusted Model 3: multiple adjusted
Beta (95% CI) p-Valuea Beta (95% CI) p-Valueb Beta (95% CI) p-Valuec
Total fat 845 113 (744; 518) 0.73 188 (759; 383) 0.52 130 (703; 442) 0.66
Fat leg 845 33.0 (253; 187) 0.77 54.2 (267; 158) 0.62 35.0 (251; 181) 0.75
Fat trunk 845 54.0 (417; 309) 0.77 96.0 (422; 230) 0.56 65.5 (390; 259) 0.69
Fat trunk/leg ratio 845 0.001 (0.038; 0.035) 0.94 0.002 (0.037; 0.034) 0.93 0.0003 (0.037; 0.036) 0.99
SATd 268 2.23 (9.50; 14.0) 0.71 0.248 (11.0; 11.5) 0.97 1.17 (9.99; 12.3) 0.84
VATe 268 0.756 (6.18; 7.70) 0.83 0.766 (7.26; 5.73) 0.82 0.279 (6.70; 6.14) 0.93
VAT/SAT ratio 268 0.017 (0.044; 0.01) 0.22 0.017 (0.045; 0.01) 0.22 0.0157 (0.044; 0.012) 0.27
Adiponectinf 844 0.169 (0.104; 0.235) <0.001 0.167 (0.096; 0.238) <0.001 0.164 (0.093; 0.236) <0.001
Lepting 844 0.08 (0.014; 0.146) 0.018 0.09 (0.021; 0.159) 0.010 0.0918 (0.023; 0.160) 0.009
Ghrelinh 834 0.09 ((0.12; 0.064) <0.001 0.096 (0.127; 0.065) <0.001 0.10 (0.13; 0.07) <0.001
a p-Value adjusted for sex.
b p-Value adjusted for sex, height and lean mass.
c p-Value adjusted for sex, height, lean mass, smoking, exercise habits, educational level, total daily energy intake, and alcohol consumption.
d Subcutaneous adipose tissue.
e Visceral adipose tissue.
f ln transformed adiponectin, SD scale.
g ln transformed leptin, SD scale.
h ln transformed ghrelin.
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The hormones adiponectin, leptin and ghrelin are known to be
involved in the regulation of hunger and satiety (Klok et al.,
2007; Swarbrick and Havel, 2008). Leptin and adiponectin regulate
the energy intake in the long term and ghrelin also in the short
term (Cummings, 2006). Circulating levels of leptin and adiponec-
tin are generally higher in women, and sex steroids including
estrogens are partly responsible for these differences (Sowers
et al., 2008).
In the present study leptin levels were positively associated
with the BPA concentration in serum, independent of adjustment
for fat mass. This is consistent with results in an experimental
study by Wei et al. in which leptin levels were increased in perina-
tal BPA-treated offspring (Wei et al., 2011). On the other hand, in a
study by Anderson et al. serum leptin levels in mice were lower in
the female offspring of dams exposed to BPA than in offspring of
control dams (Anderson et al., 2013).
Adiponectin is also secreted from adipose tissue and, in contrast
to leptin, inversely related to fat mass. In the present study adipo-
nectin levels were positively associated with BPA in serum. The
levels of adiponectin in the previously mentioned study by Ander-
son et al. were increased in BPA-exposed female offspring. In the
male offspring, adiponectin levels were lower compared with the
controls, indicating a sex-related difference. Another study showed
inhibited adiponectin release from human adipose tissue explants
in response to BPA exposure (Hugo et al., 2008).
Ghrelin is secreted from the gut and considered a hunger hor-
mone with higher levels during fasting and lower levels after
feeding. In the present study, the ghrelin level was negatively
associated with serum concentrations of BPA. In an experimental
study by Nieminen et al. where ﬁeld voles (Microtus agrestis)
were exposed subcutaneously to BPA, the opposite results were
seen: increased ghrelin levels and decreased leptin levels (Niemi-
nen et al., 2002). In an experimental study by Ferguson et al. no
differences in ghrelin serum concentrations were seen after peri-
natal BPA exposure of Sprague–Dawley rats (Ferguson et al.,
2011).
Thus, our data regarding the associations between BPA levels
and obesity-related hormones are in line with some of these exper-
imental results, but not with others.4.4. Measurements of BPA levels
The serum levels of BPA in the present study were comparable
with the levels in studies by others, as reviewed by Olsen et al.
(2012). Both free BPA and its metabolites, mainly its glucorinated
form, were included in the measured concentration. Although it
is free BPA that has a biological activity, the measurement of both
free BPA and its metabolites yields a more reliable measure of
exposure, since free BPA is rapidly glucoronidated. However, it is
more common to measure BPA in the urine. This approach has
the advantage of obtaining higher levels, which are easier to detect,
and the problem of contamination of BPA in the laboratory is
avoided since it is mainly the glucorinated form of BPA being de-
tected in the urine. However, several groups have shown that
BPA is also measurable in the circulation (Takeuchi et al., 2004;
Dirtu et al., 2008; Lee et al., 2008), and own previous data using
this approach have shown serum BPA levels to be related to lipid
inﬁltration in the vascular wall as well as being linked to high cho-
lesterol levels (Lind and Lind, 2011; Olsén et al., 2012). Further-
more, the PIVUS study has shown associations between serum
BPA levels and sex hormones and also thyroid hormones (yet
unpublished data). Thus it is likely that the determinations of
BPA are valid. If laboratory contamination or analytical problems
had been encountered, no such relationships are likely to have
been discovered. Additionally, data from contaminated samples
will always drive associations, as investigated in the present study,
towards the null hypothesis. If the data are highly corrupt, true
associations would most likely be analyzed as being non-signiﬁ-
cant, while only lightly corrupt data could still show a signiﬁcant
ﬁnding. Thus, if the BPA measurements used in the present study
would be inaccurate, this could only induce less signiﬁcant results
and not produce any false positive associations.
Contamination is a problem regarding BPA measurement. We
used blanks in the measurement process to check for this, and in
the present study contamination is not a general problem since
there are 12 individuals with levels below the LOD, being around
10% of the mean value in the sample. Thus, if a general contamina-
tion had occurred it would inﬂuence the measurements by less
than 10% compared to the mean value and therefore would not
have any major impact on the statistical analysis performed be-
tween BPA level and different markers of obesity.
M. Rönn et al. / Chemosphere 112 (2014) 42–48 47BPA has a rather short half-life and it would therefore have been
desirable to have repeated measurements of this compound in the
assessment of BPA exposure, since such approach probably have
given a more stable measure of exposure. However, as in the case
of contamination, less precise estimations of exposure could only
drive statistical analysis towards the null hypothesis and could
never induce the highly signiﬁcant relationships we report be-
tween BPA and adiponectin and ghrelin.
4.5. Limitations
This study was performed on a cohort of Caucasian elderly indi-
viduals and generalizing the ﬁndings to other ethnic- and age-
groups should be done with caution.
This sample of elderly individuals is not generally very over-
weight or obese, which should be remembered in terms of
generalizability.
4.6. Conclusion
The present study shows that BPA concentrations in serum are
associated with levels of key hormones involved in hunger and
satiety, but not with total or regional body fat measures by DXA
or MRI. Thus, the present study adds further data suggesting an
endocrine-disrupting action of BPA in humans, although possible
health consequences of our ﬁndings are not obvious at present.
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